MktsMarkets

Pulse Biosciences, Inc
NASDAQ: PLSEKey statistics
PLSE News
Stories mentioning PLSE from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 401.00 | 264.00 | 86.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Goods Sold | 370.00 | 279.00 | 0.00 | 0.00 | ||||
| Gross Profit | 31.00 | (193.00) | 0.00 | 0.00 | ||||
| Operating Expenses | ||||||||
| Research & Development | 12,590 | 10,927 | 11,393 | 12,088 | 10,313 | 10,662 | 7,703 | 7,230 |
| Sales General & Admin | 6,591 | 8,781 | 7,731 | 5,952 | ||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (19,150) | (18,253) | (20,367) | (20,275) | (18,044) | (20,261) | (13,655) | (11,726) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (24.00) | (19.00) | (6.00) | (1.00) | ||||
| Pretax Income | (19,168) | (16,795) | 87,800 | (12,680) | (11,383) | |||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income (Loss) | (18,581) | (17,433) | (19,385) | (19,168) | (16,795) | (19,385) | (12,680) | (11,383) |
| Earnings Per Share (Basic) | (0.27) | (0.26) | (0.29) | (0.28) | (0.25) | (0.33) | (0.21) | (0.20) |
| Earnings Per Share (Diluted) | ||||||||
| Weighted Average Shares Outstanding (Basic) | 67,995 | 67,395 | 67,385 | 67,276 | 67,126 | 58,398 | 61,066 | 57,180 |
| Weighted Average Shares Outstanding (Diluted) | ||||||||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PLSE
Pulse Biosciences, Inc (NASDAQ: PLSE) is a stock listed on the Nasdaq Stock Market under the ticker symbol PLSE. It last traded at $52.24 (Oct 30, 2026, 4:00 PM ET), down 5.8% on the day. That gives Pulse Biosciences a market capitalisation of $3.8B.
Over the past 52 weeks PLSE has traded between $12.56 and $58.90.
Revenue for the quarter ended Mar 31, 2026 was $401.0K; a net loss of $18.6M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $401.0K | -$18.6M | -4633.7% |
| Dec 31, 2025 | $264.0K | -$17.4M | -6603.4% |
| Sep 30, 2025 | $86.0K | -$19.4M | -22540.7% |
| Jun 30, 2025 | $0 | -$19.2M | — |
From Pulse Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…